Registration Open for 1st Cancer Cachexia Conference in Boston, MA on September 21-23, 2012
i-Newswire,
2012-05-25
We are pleased to announce that registration is now open for the first Cancer Cachexia Conference entitled, “Cancer Cachexia: Molecular Mechanisms and Therapeutic Approaches” to be held in Boston, USA on September 21-23, 2012, co-hosted by The Oh
A Way To Partake In 50% Of Cancer Trials As Opposed To 5%
i-Newswire,
2012-05-21
The Comprehensive Cancer Centers of Nevada are actively putting their best foot forward when it comes to uniquely treating each patient on a case-by-case basis. Their innovative, ample cancer trials are positively affecting the community.
Northwest Bio Provides Update On Dcvax®-L Brain Cancer Trial
i-Newswire,
2012-05-17
Amendment Accepted By FDA, Enhancing and Upgrading the Trial 41 US Clinical Trial Sites Now In Operation
"Cancer with Joy" Published By Morgan James Publishing Of NYC
i-Newswire,
2012-04-14
1,500,000+ Diagnosed with Cancer Annually in the United States Can Discover How to Transform the Fear of Dying from Cancer into Happiness
Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer Without Toxicity
i-Newswire,
2012-02-08
Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors.
Dharamshila Hospital Start Its Cancer OPD In Ford Hospital Patna, Bihar From 4th-5th Feburary 2012
i-Newswire,
2012-02-02
Bihar has recorded an alarming rise in the incidence of cancer with an estimated 200,000 people suffering from this killer disease. Lack of awareness among the people about the disease coupled with illiteracy and poverty have exposed them to the dise
Institute for Myeloma and Bone Cancer Research Presents NEW DATA at the American Society of Hematology Meeting 2011
i-Newswire,
2011-11-23
Three key studies in the field of multiple myeloma to be presented by Dr. James Berenson and the staff of the Institute for Myeloma and Bone Cancer Research, at the 53rd Annual Meeting of the American Society of Hematology, December 10-13, 2011.
Queens NYC Rehab Center Invites Public to MasquerWalk A Thon by CFSCGOnline.com
i-Newswire,
2011-10-28
The Queens Center for Rehabilitation and Healthcare, a short term rehab institution managed by the Centers for Specialty Care Group, is inviting the community to join its annual MasquerWalk A Thon for Breast Cancer awareness.
Ronco Supports The Fight Against Breast Cancer
i-Newswire,
2011-10-05
As part of its social responsibility program, throughout October, for every case of pink gloves sold, Ronco will donate 50 cents to the Canadian Breast Cancer Foundation.
New Life-Extending Cancer Pills Launched In UK
i-Newswire,
2011-09-21
A new oral therapy for prostate cancer, abiraterone acetate (Zytiga), has been launched in the UK and is likely to become available on the NHS in the New Year if a review by the National Institute for Health & Clinical Excellence(NICE) is favourable.
Dr. Daniel Jae Kim Continues Success of The Oncology Institute of Hope and Innovation in Anaheim
i-Newswire,
2011-09-16
Anaheim, CA 9/16/2011 – Dr. Daniel Jae Kim, along with the outstanding oncologists and hematologists from The Oncology Institute of Hope and Innovation, are celebrating 14 months of success at their Anaheim center.
NYC Nursing Home Network Centers for Specialty Care Group Shares the Love at Wyckoff Hospital Event
i-Newswire,
2011-09-15
Centers for Specialty Care Group, a network of rehab centers in New York, contributed to the annual Wyckoff Hospital Cancer Survivor Picnic by providing free beauty makeovers and gifts to survivors and other guests.
New Life-Extending Cancer Pills Finally Approved For Use In Europe
i-Newswire,
2011-09-12
A new oral therapy for prostate cancer, abiraterone acetate (Zytiga), has been approved by the European Commission, after an accelerated review by the European Medicines Agency.
Catherine Case Szarwark Reports Adults in Toyland Casino Night a Success
i-Newswire,
2011-09-11
According to attendee Catherine Case Szarwark, the November 4, 2010 Adults in Toyland Casino Night proved to be a highly successful event. Catherine Case Szarwark reported that the event raised both funds and awareness.
IMER Announces Live Advanced Melanoma Webcast During a 1-Day CME-Certified Conference for Community
i-Newswire,
2011-09-06
Jeffrey S. Weber, MD, PhD, of the H. Lee Moffitt Cancer Center leads a 1-day conference to provide clinicians with an update on the science of melanoma, pertinent clinical trial information, investigational agents, and their unusual adverse effects.
Method Of Stopping Production Of Cancerous Cells Including Cancerous Stem Cells
i-Newswire,
2011-08-30
Method of stopping production of cancerous cells including cancerous stem cells, destroying the existing ones and preventing the appearance of new generations of cancerous cells, by using potential telomerase inhibitors in an ‘in vitro’ setting.
Anticort A Procaine Based Drug In The Treatment Of A Patient With Incurable Cancer
i-Newswire,
2011-08-19
Anticort is a drug intended for the treatment of incurable cancers, where all the other therapeutic means had been exhausted and the patient gave up treatment, but not yet ready for hospice and "end of life" solution.
2011 Eortc Cancer Symposium
i-Newswire,
2011-08-18
A major international cancer conference is to be held at the European Parliament during 7-9 September 2011, to examine the importance of using a patient’s perception and experience when undergoing new and pioneering clinical trials, which can help,
Procaine Turns-Off Telomerase And Destroys Cancerous Cells - A Potential New Treatment Of Cancer
i-Newswire,
2011-08-10
Procaine is a drug that turns off telomerase, stops production of cancer cells & destroys the same. Procaine is a candidate for potential treatment of cancer.
Nashville Oncologist Dr. Jerry Michael Foster MD Expands Consulting Services
i-Newswire,
2011-07-20
Dr. Jerry Michael Foster MD, a veteran medical practitioner in the greater Nashville, TN area announces a new transition. Using his many years of experience in the fields of internal medicine and oncology.
Dr. Isaac Eliaz Talks About the Future of Cancer Prevention
i-Newswire,
2011-07-08
Isaac Eliaz, M.D., L.Ac., M.S., a world-renowned pioneer in natural medicine, shares the latest news in the prevention and treatment of cancer at the American Academy of Anti-Aging Medicine (A4M) Integrative Oncology Fellowship.
The Oncology Institute of Hope and Innovation Adds New Doctor to Lakewood/Long Beach Practice
i-Newswire,
2011-06-23
Lakewood/Long Beach, CA 6/23/2011 – The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the upcoming addition of Dr. Cannon Milani to the team of Oncologi
Intervention Insights Releases Conference Report, "Personalized Medicine: Promises and Perils for Community Oncology and Payers."
i-Newswire,
2011-06-20
Intervention Insights, Inc., a company that offers a personalized medicine service for oncologists, released a report summarizing the inaugural conference, Personalized Medicine: Promises and Perils for Community Oncology and Payers.
New Study Spotlights Potential of Virus To Treat Certain Lung Cancer Patients
i-Newswire,
2011-06-20
A new study reports that reovirus has the potential to treat certain lung cancer patients, when the reovirus is combined with two other substances known as paclitaxel and carboplatin.
The Oncology Institute of Hope and Innovation Grows Downey Practice
i-Newswire,
2011-06-10
Downey, CA 6/10/2011 – The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the upcoming addition of Dr. Alexander Gaitanis as part of an expansion of thei